conect4children's Podcast

Kawasaki disease is an acute febrile illness of unknown cause that primarily affects children younger than 5 years of age.

The clinical trial “KD-CAAP” studies the effectiveness of adding a new element to the standard treatment for this disease. What are the hopes for Kawasaki disease treatment and patients? 

Listen to our podcast with Prof. Paul Brogan, joined chief investigator of the KD-CAAP trial, that will explain you what Kawasaki disease is, why KD-CAAP trial is important, and what are the perspectives around this disease that affects mostly children.

Kawasaki disease, also known as Kawasaki syndrome, is an acute febrile illness of unknown cause that primarily affects children younger than 5 years of age.

KD-CAAP proof of viability study assesses the effectiveness of adding steroids to standard treatment in children with Kawasaki Disease.

Why is it important to improve paediatric patient’s lives? How is c4c supporting this study?

Listen to our podcast with Prof. Paul Brogan, joined chief investigator of the KD-CAAP trial!

conect4children podcast is back with a new episode around Science communication! 

Why is Science communication essential nowadays, especially for an European Network as conect4children? 
How to efficiently communicate science? 
How to overcome the challenges around fake news? 

Join our Claudio Fracasso, Pediatric Clinical Director in Pfizer Pediatric Center of Excellence, and Lindsey Hunter, Network Education Training Team Manager at Fondazione Penta Onlus for an interesting conversation around Science Communication! 

In today’s episode, we’re exploring what CasperCF study is. What’s the objective of this study?  Why is it important for children?

Listen to the full episode with Jacob Bradbury, Graduate research assistant at Exeter University! 

In today’s episode, we’re focusing on cASPerCF trial, a study that is trying to find the right dose of posaconazole for children & young people with Cystic Fibrosis and Aspergillus infection

Why is this study important? What are the challenges? Why is c4c important for this ongoing trial?

Listen to the full episode with Adilia Warris, Chief investigator of the cASPerCF trial, professor at the University of Exeter!